Jérémie Richard, Ph.D.

Assistant Professor @uOttawa • Director @AppliedPsySci • Clinical Psychologist • Affiliate Researcher @JHPsychedelics • @mcgillu alumnus

[Jérémie Richard, Ph.D. @JRichardPhD]

We are continuing to recruit for this ongoing study investigating the impact of psychedelic use on behavioral addictions.

Please consider completing this survey if you qualify. I am also conducting an optional semi-structured interview to learn more from certain participants.

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Have you struggled with a behavioral addiction and taken a psychedelic substance in the past? We are seeking individuals to participate in a research study looking into the effects of psychedelics on a number of addictive behaviors including problems with gambling, video gaming, internet/social media, pornography and other sexual behaviors, and shopping and buying behaviors. To learn more and participate, visit: https://t.co/ahhiuqS9rc

[Jérémie Richard, Ph.D. @JRichardPhD]

... enter HiTOP.

https://t.co/5LrfjqEDsI

[Nicholas Fabiano, MD @NTFabiano]

This is a map of repetition among all symptoms in the DSM-5.

The majority of symptoms are found across disorders, yet we treat them as separate entities.

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

ISRP always puts on a great conference, and this one will be no different! Abstract submissions have been extended to Oct 31st.
#PsychedelicScience #ISRP2026

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Announcing the launch of a new study here at the CPCR! This study will test whether two substances often referred to as psychedelics — psilocybin & MDMA — can address PTSD symptoms and improve quality of life. Participants will receive guided dosing sessions, professional psychological support, and follow-ups over several months. If you’re a veteran living with PTSD, you may be eligible to take part in this important research. Please share widely to whoever may be eligible and interested in participating.
Start with our online eligibility survey: https://t.co/gqMtKYDfbU

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Missed our summer newsletter?
Catch up on the latest updates from the CPCR and subscribe to stay in the loop:
🔗 https://t.co/TX65J7nf7e

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

CPCR post doc, Dr. Jérémie Richard, has started a new position as Assistant Professor at the University of Ottawa. Dr. Richard is joining the Clinical Psychology and Psychedelic Studies faculty in the School of Psychology and will be teaching core graduate coursework in both programs. Over the coming years, Dr. Richard aims to continue developing his research program at the intersection of psychedelics and health, developing knowledge with direct relevance to patients, clinicians, researchers, and policymakers.

Congratulations, Dr. Richard! 🎉

[Trends in Cognitive Sciences @TrendsCognSci]

The emotional architecture of the psychedelic brain

Review by Flora Moujaes (@floramoujaes), Nathalie Rieser (@NathalieRieser), Lydia Belinger, Marcus Herdener, Zarmeen Zahid (@zarmeen_z), & Katrin Preller (@KatrinPreller)
https://t.co/8AB10NixYJ

[Sandeep Nayak @sdpnayak]

https://t.co/8BgwKye8id

[Katherine Cheung @Katherine_Chg]

"Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns"

https://t.co/4d3AVYI7Lt

[Jérémie Richard, Ph.D. @JRichardPhD]

Great science, great people.

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Reminiscing on all the great presentations and conversations we had at the Gordon Research Conference @GordonConf. Our faculty and postdocs were thrilled for the opportunity to present our recent findings. Special thanks to organizers @kwanalexc & @VVyazovskiy
@FredBarrettPhD, @existwell, @PraachiTiwari, @r_ehrenkranz , @NathalieRieser, @JRichardPhD, @SeanPGoldy, @zarmeen_z, @winstonian3

[Jérémie Richard, Ph.D. @JRichardPhD]

The 2024 conference in New Orleans was incredible. I highly recommend to anyone interested in psychedelic research ranging from preclinical to clinical investigations.

[ISRPsychedelics @ISRPsychedelics]

We're thrilled to announce that ISRP 2026 abstract submission will open on August the 15th!

Join us in New Orleans from Feb 27 - Mar 1

Oral presentations will be 15 min + 5 min Q&A

Stay tuned for more updates!

Please note only ISRP members are eligible to submit an abstract

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Associate Director, Dr. Albert Garcia-Romeu shared his insights on psychedelic therapies for psychiatric disorders. He explains the science, shifting public perception, and potential for future FDA approval for these therapies.

[Jérémie Richard, Ph.D. @JRichardPhD]

@SeanPGoldy @GordonConf Welcome home.

[Jérémie Richard, Ph.D. @JRichardPhD]

Amazing pre-clinical poster session at #GRCPsychedelics. Play the "Where's Waldo" of @JHPsychedelics postdocs and faculty. 5 is the number to beat.

[Alex Kwan 關進晞 @kwanalexc]

Poster session in full swing. Lots of exciting unpublished work. #GRCPsychedelics

[Jérémie Richard, Ph.D. @JRichardPhD]

P.S. Shout-out to all of my amazing colleagues and their incredible ongoing research projects ranging from pre-clinical to clinical research.

[Jérémie Richard, Ph.D. @JRichardPhD]

Looking forward to next week's Gordon Research Conference. This will be my first time presenting an emerging transdiagnostic model of psychedelic therapy with a primary focus on evidence-based psychotherapy. In this model, psychedelics are conceptualized as ...

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Thrilled to connect at the Neurobiology of Psychedelics Gordon Research Conference (@GordonConf) next week! CPCR researchers and fellow scientists will discuss wide range of topics, including preclinical and clinical research, drug discovery, and neuroplasticity.

[Jérémie Richard, Ph.D. @JRichardPhD]

... a tool that can foster rapid symptom reduction, increase motivation to engage with therapy and provide a groundwork for behavioral experiments.

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Last week, CPCR researchers Drs. Fred Barrett, Brandon Weiss, David Yaden, and Sandeep Nayak met with the PATH Caucus (led by @RepLouCorrea and @RepJackBergman) on Capitol Hill. In a vibrant meeting of oral presentations and Q&A, Drs. Barrett and Weiss shared their scientific findings signaling the potential for Psilocybin Therapy to be a rapid-acting, efficacious, safe, and tolerable tool for treating PTSD, alcohol use disorder, and depression among military Veterans and other Americans. We thank the PATH Caucus for their great advocacy for research on psychedelic therapy and Veteran health, and for including us in their mission.

@FredBarrettPhD @BWe1ss @ExistWell @sdpnayak

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

CPCR is hiring a postdoc to manage the operation of clinical drug trials focused on the treatment of PTSD with psychedelic therapy. Read more below!

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

Join our brain stimulation research study!

Researchers at Johns Hopkins are investigating the effects of psilocybin—a psychoactive compound found in mushrooms—on brain activity and function using transcranial magnetic stimulation, EEG, fMRI, and cognitive testing.

Scan the QR code or use the information below to learn more and apply!

410-550-2253
[email protected]